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NDM-producing Providencia rettgeri in Brazil. J Antimicrobtrain in the  state  of  São  Paulo
ear Editor,
arbapenemases are enzymes known to hydrolase almost all
ypes of -lactam antibiotics and their spread among bacte-
ia of clinical relevance are one of the main global challenges
o be overcome in the next years. NDM stands for New Delhi
etallo--lactamase which was ﬁrstly identiﬁed in 2009 in a
weden patient who had been previously hospitalized in New
elhi, India.1 Although other types of metallo--lactamases
re currently present in Brazil (until now SPM-1 has been the
ost prevalent in clinical isolates2), the ﬁrst occurrence of
DM producer was reported in a clinical isolate of Providencia
ettgeri in the beginning of 2013 in Porto Alegre/RS, Southern
egion of Brazil.3 Since then, other cases have been reported
n Brazil.
A 55 year-old diabetic and hypertensive man  was admit-
ed to a tertiary public hospital (Hospital Heliópolis) in the
ão Paulo city to undergo amputation of the 4th toe due
steomyelitis complication. The patient had a history of gas-
ric surgery for peptic ulcer ﬁve years before, but no report of
ospitalization or travel in the past 12 months. Four months
arlier, the man  reported a lesion in the same toe caused by
 trauma with iron sheet and high temperature solder. One
onth after the initial trauma the patient presented wors-
ning of pain and swelling of 4th right toe and was at that
ime admitted to a tertiary public hospital from city of São
aulo (Hospital Vila Alpina) where he received intravenous
iproﬂoxacin and clindamycin therapy to treat the bone infec-
ion (400 mg  q12h and 600 mg  q6h × 14d, respectively) without
uccess. During hospitalization at Hospital Heliópolis for
mputation of the 4th toe the patient received intravenous
eftriaxone and clindamycin therapy (1 g q12h and 600 mg
6h × 3d, respectively) and then was discharged with no signs
f infection to be followed up in the outpatient service.
Results from bone culture of the amputated toe per-
ormed at Hospital Heliópolis revealed the presence of
ram-negative bacteria. The susceptibility tests showed a
arbapenem resistance proﬁle: Etest positive for imipenem
MIC >32 mg/L), meropenem (MIC >32 mg/L) (bioMérieux Clin-
cal Diagnostics, France, according to CLSI 2015 breakpoints4)
ith Modiﬁed Hodge Test negative, and positive for metallo-
-lactamase (ML) production (Carbapenembac-Metalo® kit).
he bacterium was identiﬁed as Providencia rettgeri, accord-
ng MicroScan system (Beckman Coulter, Inc.), sensitive to
4amikacin (MIC ≤16 mg/L), gentamicin (MIC ≤4 mg/L), and
tobramycin (MIC ≤4 mg/L). In order to identify the type of ML
produced by the clinical isolate and to conﬁrm the previous
results the strain was sent to a reference laboratory at Insti-
tuto Adolf Lutz – São Paulo. The presence of blaNDM gene by
Multiplex (KPC, NDM and OXA-48) and Simplex (NDM) PCR
and the species identity was conﬁrmed by Vitek-MS system
(bioMérieux Clinical Diagnostics, France). The clinical isolate is
under investigation in order to characterize molecular aspects
of blaNDM gene and its origin. To the best of our knowledge, this
is the ﬁrst ofﬁcial report of a NDM producer Enterobacteriaceae
isolated in the state of São Paulo.
Worldwide dissemination of broad-spectrum carbapen-
emases is a real threat for the modern medicine. New
Delhi Metallo--lactamase (NDM) is a new type of Metallo--
Lactamase that precludes the use of last resort carbapenems.
In Brazil, the occurrence of NDM is emerging, especially in
the South and Southeast regions. In conclusion, the ﬁrst NDM
producer strain has been detected in the most populous state
of Brazil with the largest economy, underscoring the need to
urgently implement even more  efforts to identify and prevent
the spreading of this threat in Brazil.
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